CB
The startup develops mitochondrial drugs targeting metabolic and intractable inflammatory diseases, focusing on rare conditions with significant unmet medical needs. By utilizing a differentiated research and development platform, the company aims to provide effective treatments that enhance the quality of life for patients suffering from these diseases.
Updated 20 months ago
Funding
$5.4M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Funding rounds are not available yet.
Founders
Founder details are not available yet.
Product
Features
- The startup develops mitochondrial drugs targeting metabolic and intractable inflammatory diseases, focusing on rare conditions with significant unmet medical needs. By utilizing a differentiated research and development platform, the company aims to provide effective treatments that enhance the quality of life for patients suffering from these diseases.